Skip to main content
Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
69.15
-1.55 (-2.19%)
At close: Mar 9, 2026, 4:00 PM EDT
69.80
+0.65 (0.94%)
After-hours: Mar 9, 2026, 5:46 PM EDT

Nektar Therapeutics Employees

Nektar Therapeutics had 61 employees as of December 31, 2024. The number of employees decreased by 76 or -55.47% compared to the previous year.

Employees
61
Change (1Y)
-76
Growth (1Y)
-55.47%
Revenue / Employee
$1,026,230
Profits / Employee
-$1,979,279
Market Cap
1.93B

Employees Chart

Employees History

Date Employees Change Growth
Dec 31, 202461-76-55.47%
Dec 31, 2023137-79-36.57%
Dec 31, 2022216-524-70.81%
Dec 31, 2021740223.06%
Dec 31, 2020718-5-0.69%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Related Stocks

Company Name Employees
Ultragenyx Pharmaceutical 1,371
Iovance Biotherapeutics 975
Ascentage Pharma Group International 605
Syndax Pharmaceuticals 298
Celldex Therapeutics 198
Soleno Therapeutics 182
Stoke Therapeutics 128
Aurinia Pharmaceuticals 128
Employee Rankings

NKTR News

More News